好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

2019 Annual Meeting | S30 - Brain Cancer: From Epidemiology to Quality of Life

Tuesday 05/07/19
03:30 PM - 05:30 PM EDT Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Platform Session
Na Tosha N. Gatson, MD, PhD, FAAN, Scott R. Plotkin, MD, PhD, FAAN, Maciej M. Mrugala, MD, PhD, MPH, FAAN
Neuro-oncology
2.00 CME credits

Program Materials Program Evaluations

Event Timeline
03:30 PM - 03:41 PM EDT Abstract 001 - Incidence and Natural History of H3 K27M-mutated Midline Gliomas in Adults
Karisa C. Schreck, MD, PhD
03:41 PM - 03:52 PM EDT Abstract 002 - Absolute Lymphocyte Count in Patients with Glioblastoma Treated with Temozolomide Chemoradiation.
Anas Ahmed Moahmmed Saeed Bamashmos, MD
03:52 PM - 04:03 PM EDT Abstract 003 - Treatment-related adverse effects in patients with brain cancer: identification of distinctive features for pseudoprogression and treatment-induced necrosis.
Sebastian Friedrich Winter
04:03 PM - 04:14 PM EDT Abstract 004 - Primary Brain and Central Nervous System Tumor Treatment and Survival in the United States, 2004-2014
Catherine Garcia, MD
04:14 PM - 04:25 PM EDT Abstract 005 - Prognostic Awareness and Illness Understanding in Patients with Malignant Glioma and their Caregivers
Deborah Forst, MD
04:25 PM - 04:36 PM EDT Abstract 006 - A Non-interventional Study of Adjunctive Lacosamide Therapy in Patients With Brain Tumor-related Epilepsy
Roberto Ruda, MD, Bjorn Steiniger Brach
04:36 PM - 04:47 PM EDT Abstract 007 - Longer Median Overall Survival in Glioblastoma Patients from Racial and Ethnical Minority Groups
Sharon Yu
04:47 PM - 04:58 PM EDT Abstract 008 - Treatment-Related Decisions in Malignant Gliomas: A Feasibility Study
Jessica F. Occhiogrosso
04:58 PM - 05:09 PM EDT Abstract 009 - Impact of Travel Distance to Care Facility on Survival in Patients with Glioblastoma: A Retrospective Study Using the National Cancer Database
Jay-Jiguang Zhu, MD, PhD, FAAN
05:10 PM - 05:30 PM EDT Q&A Q&A Panel with Authors
Faculty Disclosures
Na Tosha N. Gatson, MD, PhD, FAAN Dr. Gatson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GT Medical Technologies. Dr. Gatson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Menarini Silicon Biosystems. Dr. Gatson has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NuvOx Pharmaceuticals. Dr. Gatson has received publishing royalties from a publication relating to health care. Dr. Gatson has a non-compensated relationship as a Board Member with Society for Equity in Neurosciences (SEQUINS) that is relevant to AAN interests or activities.
Scott R. Plotkin, MD, PhD, FAAN Dr. Plotkin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NFlection Therapeutics. Dr. Plotkin has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Akouos. Dr. Plotkin has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SonALAsense. Dr. Plotkin has stock in NFlection Therapeutics. Dr. Plotkin has stock in NF2 Therapeutics. Dr. Plotkin has stock in SonALAsense. Dr. Plotkin has received research support from Children's Tumor Foundation. Dr. Plotkin has received research support from Department of Defense. Dr. Plotkin has received research support from National Institutes of Health. Dr. Plotkin has received intellectual property interests from a discovery or technology relating to health care.
Maciej M. Mrugala, MD, PhD, MPH, FAAN Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Veevo Biomedicines Inc. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arbor Pharmaceuticals. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra-Zeneca. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Mrugala has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyiatec . The institution of Dr. Mrugala has received research support from Arbor Pharmaceuticals. Dr. Mrugala has a non-compensated relationship as a Program Director with Society for Neuro-Oncology that is relevant to AAN interests or activities.
No disclosure on file
Deborah Forst, MD Dr. Forst has stock in Eli Lilly. Dr. Forst has received research support from Conquer Cancer Foundation of the American Society of Clinical Oncology. Dr. Forst has received research support from Palliative Care Research Cooperative Group. Dr. Forst has received research support from American Cancer Society Institutional Research Grant.
Areej El-Jawahri No disclosure on file
Jane Chan, MD No disclosure on file
Joy E. Burke, MD No disclosure on file
Chinazom U. Ibegbu, MD Dr. Ibegbu has nothing to disclose.
Sylvia C. Kurz, MD, PhD Dr. Kurz has received personal compensation in the range of $0-$499 for serving as a Consultant for Advanced Accelerator Applications.
Jorg Dietrich, MD, PhD, FAAN Dr. Dietrich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Dietrich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Dietrich has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ono Therapeutics. Dr. Dietrich has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Johnson & Johnson. Dr. Dietrich has received publishing royalties from a publication relating to health care.
Jay-Jiguang Zhu, MD, PhD, FAAN Dr. Zhu has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novocure, INC, Japan. An immediate family member of Dr. Zhu has stock in Abbott lab. The institution of Dr. Zhu has received research support from NRG NIH. The institution of Dr. Zhu has received research support from Novocure, Inc. The institution of Dr. Zhu has received research support from Five Prime pharmaceutical. The institution of Dr. Zhu has received research support from Denovo, inc. The institution of Dr. Zhu has received research support from Boston Biomedical Sumitomo Dainippon Pharma Global Oncology. The institution of Dr. Zhu has received research support from CNS pharmaceutical. The institution of Dr. Zhu has received research support from ABM Therapeutics Corporation . The institution of Dr. Zhu has received research support from Chimerix Inc.
Nimish A. Mohile, MD, FAAN The institution of Dr. Mohile has received research support from Novocure.
Roberto Ruda, MD Dr. Ruda has nothing to disclose.
Karisa C. Schreck, MD, PhD Dr. Schreck has received personal compensation in the range of $0-$499 for serving as a Consultant for Nurix. Dr. Schreck has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Schreck has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Advarra LLC. The institution of Dr. Schreck has received research support from Springworks Therapeutics. Dr. Schreck has received personal compensation in the range of $500-$4,999 for serving as a speaker with Springworks Therapeutics.
Lauryn Hemminger Dr. Hemminger has nothing to disclose.
Iryna Leunikava No disclosure on file
Jessica F. Occhiogrosso Ms. Occhiogrosso has nothing to disclose.
Jennifer N. Serventi, PA Ms. Serventi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novocure.
Marc De Backer, MD, FBCPM, MBA No disclosure on file
Asad Ali, MD No disclosure on file
Matthias Holdhoff No disclosure on file
Alona Muzikansky No disclosure on file
Catherine Garcia, MD Dr. Garcia has nothing to disclose.
Sebastian Friedrich Winter Mr. Winter has nothing to disclose.
Surabhi Ranjan, MD Dr. Ranjan has nothing to disclose.
Sharon Yu No disclosure on file
Bjorn Steiniger Brach No disclosure on file
Maria Martinez-Lage, MD The institution of Dr. Martinez-Lage has received research support from NIH.
Helen Shih No disclosure on file
Anas Ahmed Moahmmed Saeed Bamashmos, MD No disclosure on file